Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
Holding EVH?
Track your performance easily
EVH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.88 - $35.00
Previous CloseN/A
Volume268.11K
Average Volume (3M)2.47M
Market Cap
$1.18B
Enterprise Value$3.96B
Total Cash (Recent Filing)$178.90M
Total Debt (Recent Filing)$120.28M
Price to Earnings (P/E)―
Beta0.33
Next Earnings
Feb 19, 2025EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding116,563,910
10 Day Avg. Volume2,570,145
30 Day Avg. Volume2,471,604
Standard Deviation0.19
R-Squared0.16
Alpha0.00499
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.47
Price to Cash Flow (P/CF)15.60
P/FCF Ratio23.50
Enterprise Value/Market Cap3.34
Enterprise Value/Revenue1.61
Enterprise Value/Gross Profit8.60
Enterprise Value/Ebitda75.24
Forecast
1Y Price Target
$20.43Price Target Upside101.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Evolent Health News
Bulls Say, Bears Say
Bulls Say
Client RetentionEvolent was able to maintain 100% client retention through the Performance Suite contract negotiations.
New Business ActivityEvolent Health entered into six new agreements, including one PS oncology contract and five Tech & Services contracts, highlighting strong new business activity.
Revenue And EBITDA GrowthThe company expects 15%+ revenue growth and 20%+ adjusted EBITDA growth in the long term, despite current setbacks.
Bears Say
Cost ChallengesHigher oncology costs led to a significant EBITDA miss and a guide down for the full year, with continued pressure expected in the future.
Customer ImpactSeveral of EVH's customers fully terminated MA plans, resulting in an expected headwind of $20 million.
Financial PerformanceEvolent Health's revenue and adjusted EBITDA for 3Q24 fell short of estimates due to higher-than-expected costs in the Performance Suite business.
---
Ownership Overview
1.29% Insiders
38.29% Mutual Funds
2.04% Other Institutional Investors
43.11% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EVH FAQ
What was Evolent Health’s price range in the past 12 months?
Evolent Health lowest stock price was $9.88 and its highest was $35.00 in the past 12 months.
What is Evolent Health’s market cap?
Evolent Health’s market cap is $1.18B.
When is Evolent Health’s upcoming earnings report date?
Evolent Health’s upcoming earnings report date is Feb 19, 2025 which is in 32 days.
How were Evolent Health’s earnings last quarter?
Evolent Health released its earnings results on Nov 07, 2024. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.31 by -$0.27.
Is Evolent Health overvalued?
According to Wall Street analysts Evolent Health’s price is currently Undervalued.
Does Evolent Health pay dividends?
Evolent Health does not currently pay dividends.
What is Evolent Health’s EPS estimate?
Evolent Health’s EPS estimate is 0.06.
How many shares outstanding does Evolent Health have?
Evolent Health has 116,563,910 shares outstanding.
What happened to Evolent Health’s price movement after its last earnings report?
Evolent Health reported an EPS of $0.04 in its last earnings report, missing expectations of $0.31. Following the earnings report the stock price went down -45.625%.
Which hedge fund is a major shareholder of Evolent Health?
Currently, no hedge funds are holding shares in EVH
---
Evolent Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.43 (101.08% Upside)
$20.43 (101.08% Upside)
Blogger Sentiment
Bullish
EVH Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 576.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.25%
12-Months-Change
Fundamentals
Return on Equity
-6.95%
Trailing 12-Months
Asset Growth
-6.29%
Trailing 12-Months
Company Description
Evolent Health
Evolent Health (EVH) is a healthcare solutions company that partners with healthcare providers and payers to improve clinical and financial performance. The company operates within the healthcare sector, focusing on enhancing the quality of care while reducing costs. Evolent Health offers a range of services, including value-based care solutions, administrative services, and technology-enabled clinical programs designed to optimize patient outcomes and streamline operations for its clients.
---
EVH Company Deck
---
EVH Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted Evolent's strong market position and record business signings, but was overshadowed by significant challenges related to increased medical costs, earnings shortfall, and the need for additional rate negotiations. Despite long-term growth expectations, the immediate financial performance and operational hurdles present a cautious outlook.Read More>---
EVH Stock 12 Month Forecast
Average Price Target
$20.43
▲(101.08% Upside)
Technical Analysis
Best Analysts Covering EVH
1 Year
1 Year Success Rate
20/46 ratings generated profit
1 Year Average Return
+12.66%
reiterated a buy rating 6 days ago
Copying Richard Close's trades and holding each position for 1 Year would result in 43.48% of your transactions generating a profit, with an average return of +12.66% per trade.
---